566 filings
Page 6 of 29
6-K
3jeay dyvuqyn
16 Apr 20
AETERNAzentaris Receives Nasdaq Notice of non-compliance; nO IMMEDIATE IMPACT ON LISTING
12:00am
6-K
558nyd2vrbn4tl1v
15 Apr 20
AETERNAzentaris to present at the April 2020 virtual investor summit
10:49am
6-K
sbe8fswcy4a64jlh3xbj
7 Apr 20
AETERNAzentaris announces EMA Decision TO AccepT A modification To an agreed pediatric investigation plan for macimorelin
3:21pm
6-K
18bwg v38gdk0abt7d
6 Apr 20
AETERNAzentaris announces positive Results In Dose-finding pediatric study of Macimorelin
9:30am
6-K
2kmhto39vitgs 0yt
31 Mar 20
Consolidated Financial Statements
12:00am
6-K
hgruq8e
26 Mar 20
Current report (foreign)
3:02pm
6-K
kvika1exg f7yzrm
12 Mar 20
Aeterna Zentaris Announces Settlement of Previously Disclosed class-action lawsuit
2:38pm
6-K
pq35e3 8zgx
28 Feb 20
Current report (foreign)
4:05pm
6-K
dkgw9
21 Feb 20
Aeterna Zentaris Announces CLOSING OF $4.5 Million
4:10pm
6-K
dikc3j
21 Feb 20
Current report (foreign)
9:31am
6-K
79r0dk9
20 Feb 20
Aeterna Zentaris Announces $4.5 Million Registered Direct Offering priced at-the-market
6:15am
6-K
72migbt6u1 rl5
12 Feb 20
AETERNAzentaris to PRESENT at Noble Capital Markets’ 16th Annual Investor Conference
8:57am
6-K
vjc0f
28 Jan 20
AETERNAzentaris announces completion of patient recruitment In Dose-finding pediatric study of Macimorelin
12:28pm
6-K
0gn dc6th0wgp2
27 Jan 20
Current report (foreign)
4:34pm
6-K
0a0g64hdzaw
8 Jan 20
Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement
4:01pm
6-K
4s3g1
18 Dec 19
Aeterna Zentaris Announces Publication of GHD Management Guidelines
9:09am
6-K
esu60r3
16 Dec 19
Aeterna Zentaris Announces 2020 Director Changes
9:00am
6-K
vxig owin
8 Nov 19
Aeterna Zentaris Reports Third Quarter 2019 Financial and Operating Results
12:00am
6-K
hu0zlzkdwk25aj0xipem
7 Nov 19
Condensed Interim Consolidated Financial Statements
5:01pm
6-K
e0xgzwj5k1
8 Oct 19
Material Change Report
11:58am